Senti Biosciences Holdings (SNTI) Accounts Payables (2021 - 2025)

Senti Biosciences Holdings' Accounts Payables history runs 5 years deep, the most recent figure standing at $5.4 million for Q4 2025.

• In Q4 2025, Accounts Payables rose 268.23% year-over-year to $5.4 million; the TTM figure through Dec 2025 stood at $5.4 million (up 268.23% YoY), while the FY2025 annual figure was $5.4 million, up 268.23% from the prior year.
• Accounts Payables was $5.4 million for Q4 2025 at Senti Biosciences Holdings, up from $5.1 million in the prior quarter.
• In the past five years, Accounts Payables ranged from a high of $12.6 million in Q4 2022 to a low of $28.0 in Q1 2021.
• Historically, Accounts Payables has averaged $4.1 million across 5 years, with a median of $3.8 million in 2025.
• The sharpest annual moves came in 2022 and 2024: Accounts Payables soared 14015194.12% in 2022, then slumped 76.34% in 2024.
• A 5-year view of Accounts Payables shows it stood at $5.3 million in 2021, then soared by 135.9% to $12.6 million in 2022, then tumbled by 52.87% to $5.9 million in 2023, then tumbled by 75.47% to $1.5 million in 2024, then surged by 268.23% to $5.4 million in 2025.
• The last three Accounts Payables figures came in at $5.4 million (Q4 2025), $5.1 million (Q3 2025), and $3.6 million (Q2 2025), per Business Quant data.